Tenaya Therapeutics Stock (NASDAQ: TNYA) stock price, news, charts, stock research, profile.
Open | $4.210 |
Close | $4.210 |
Volume / Avg. | 301.019K / 419.456K |
Day Range | 4.075 - 4.245 |
52 Wk Range | 1.660 - 8.091 |
Market Cap | $314.651M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 41 |
Short Interest | 6.13% |
Days to Cover | 16.34 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Tenaya Therapeutics (NASDAQ: TNYA) through any online brokerage.
Other companies in Tenaya Therapeutics’s space includes: Zura Bio (NASDAQ:ZURA), Skye Bioscience (NASDAQ:SKYE), Precigen (NASDAQ:PGEN), Inozyme Pharma (NASDAQ:INZY) and Replimune Group (NASDAQ:REPL).
The latest price target for Tenaya Therapeutics (NASDAQ: TNYA) was reported by Canaccord Genuity on Thursday, May 16, 2024. The analyst firm set a price target for 16.00 expecting TNYA to rise to within 12 months (a possible 299.26% upside). 11 analyst firms have reported ratings in the last year.
The stock price for Tenaya Therapeutics (NASDAQ: TNYA) is $4.0074 last updated May 31, 2024 at 5:13 PM EDT.
There are no upcoming dividends for Tenaya Therapeutics.
Tenaya Therapeutics’s Q2 earnings are confirmed for Wednesday, August 7, 2024.
There is no upcoming split for Tenaya Therapeutics.
Tenaya Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.